awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37760222-F8D06EBC-BC14-421C-9367-060D4CE76E65
Q37760222-F8D06EBC-BC14-421C-9367-060D4CE76E65
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37760222-F8D06EBC-BC14-421C-9367-060D4CE76E65
Zibotentan for the treatment of castrate-resistant prostate cancer.
P2860
Q37760222-F8D06EBC-BC14-421C-9367-060D4CE76E65
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37760222-F8D06EBC-BC14-421C-9367-060D4CE76E65
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b8b55fdbd34091b678cc07053d7aa3440ca49bbf
P2860
Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer.